Radiotherapy & Oncology
Volume 93, Issue 3 , Pages 516-523, December 2009

Oral cavity squamous cell carcinoma in 260 patients aged 80years or more

  • Cécile Ortholan

      Affiliations

    • Department of Radiotherapy, Centre Antoine-Lacassagne, Nice, France
    • Corresponding Author InformationCorresponding author. Address: Centre Antoine-Lacassagne, Department of Radiotherapy, 33 Avenue de Valombrose, 06189 Nice Cedex 2, France.
  • ,
  • Antoine Lusinchi

      Affiliations

    • Department of Radiotherapy, Institut de Cancérologie Gustave Roussy, Villejuif, France
  • ,
  • Antoine Italiano

      Affiliations

    • Department of Medical Oncology, Centre Antoine-Lacassagne, Nice, France
  • ,
  • René-Jean Bensadoun

      Affiliations

    • Department of Radiotherapy, Centre Antoine-Lacassagne, Nice, France
  • ,
  • Anne Auperin

      Affiliations

    • Department of Biostatistics and Epidemiology, Institut de Cancérologie Gustave Roussy, Villejuif, France
  • ,
  • Gilles Poissonnet

      Affiliations

    • Department of Head and Neck Surgery, Centre Antoine-Lacassagne, Nice, France
  • ,
  • Alexandre Bozec

      Affiliations

    • Department of Head and Neck Surgery, Centre Antoine-Lacassagne, Nice, France
  • ,
  • Rodrigo Arriagada

      Affiliations

    • Department of Radiotherapy, Institut de Cancérologie Gustave Roussy, Villejuif, France
  • ,
  • Stéphane Temam

      Affiliations

    • Department of Head and Neck Surgery, Institut de Cancérologie Gustave Roussy, Villejuif, France
  • ,
  • Karen Benezery

      Affiliations

    • Department of Radiotherapy, Centre Antoine-Lacassagne, Nice, France
  • ,
  • Juliette Thariat

      Affiliations

    • Department of Radiotherapy, Centre Antoine-Lacassagne, Nice, France
  • ,
  • Yungan Tao

      Affiliations

    • Department of Radiotherapy, Institut de Cancérologie Gustave Roussy, Villejuif, France
  • ,
  • François Janot

      Affiliations

    • Department of Head and Neck Surgery, Institut de Cancérologie Gustave Roussy, Villejuif, France
  • ,
  • Gérard Mamelle

      Affiliations

    • Department of Head and Neck Surgery, Institut de Cancérologie Gustave Roussy, Villejuif, France
  • ,
  • Jacques Vallicioni

      Affiliations

    • Department of Head and Neck Surgery, Centre Antoine-Lacassagne, Nice, France
  • ,
  • Philippe Follana

      Affiliations

    • Department of Radiotherapy, Institut de Cancérologie Gustave Roussy, Villejuif, France
  • ,
  • Frédéric Peyrade

      Affiliations

    • Department of Radiotherapy, Institut de Cancérologie Gustave Roussy, Villejuif, France
  • ,
  • Anne Sudaka

      Affiliations

    • Department of Pathology, Centre Antoine-Lacassagne, Nice, France
  • ,
  • Jean Bourhis

      Affiliations

    • Department of Radiotherapy, Institut de Cancérologie Gustave Roussy, Villejuif, France
    • These authors contributed equally to this work.
  • ,
  • Olivier Dassonville

      Affiliations

    • Department of Head and Neck Surgery, Centre Antoine-Lacassagne, Nice, France
    • These authors contributed equally to this work.

Received 29 March 2009; received in revised form 26 July 2009; accepted 27 July 2009. published online 25 August 2009.

Abstract 

Purpose

We report the experience of two French cancer centers in the treatment of oral cavity squamous cell carcinoma (SCC) in patients aged ⩾80years.

Materials and methods

Two hundred and sixty patients aged ⩾80years with a primary oral cavity SCC were included in this retrospective analysis.

Results

Sex ratio was near to 1. Tobacco or alcohol intoxication was the main risk factor for 66% of men and 16% of women and leukoplakia, lichen planus, or oral traumatism for 55% of women and 11% of men (p<0.0001). Two hundred patients received a loco-regional (LR) treatment with a curative intent (surgery and/or radiotherapy), 29 with a palliative intent and 31 did not receive a LR treatment. Curative treatments were initially planned to be adapted to age in 118 patients (59%). The median disease-specific survival (DSS) was 29months. In multivariate analysis, the independent prognostic factors for DSS were stage (HR=0.42 [0.24–0.72]), age (HR=0.43 [0.24–0.75]) and performance status (HR=0.50 [0.27–0.95]). The median overall survival (OS) was 14months. In multivariate analysis, the independent prognostic factors for OS were age (HR=0.52 [0.35–0.79]), stage (HR=0.56 [0.38–0.84]), tumor differentiation (HR=0.60 [0.33–0.93]) and performance status (HR=0.6 [0.37–0.97]). In patients treated with a curative intent, treatment adapted to age was not associated with a decreased overall survival or disease-specific survival as compared with the standard treatment. However, prophylactic lymph node treatment in stages I–II tumors decreased the rate of nodal recurrence from 38% to 6% (p=0.01).

Conclusion

This study emphasizes the need for prospective evaluation of standard and adapted schedules in elderly patients with oral cavity cancer.

Keywords: Oral cavity, Squamous cell carcinoma, Elderly, Geriatric oncology, Radiotherapy, Surgery

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0167-8140(09)00433-2

doi:10.1016/j.radonc.2009.07.015

Radiotherapy & Oncology
Volume 93, Issue 3 , Pages 516-523, December 2009